LABD: ETF To Benefit From Downturns In The Biotech Industry
Source: SeekingAlpha
2026-01-26 09:19:21 ET
Fast Facts About the Direxion Daily S&P Biotech Bear 3x Shares ETF
Read the full article on Seeking Alpha
For further details see:
LABD: ETF To Benefit From Downturns In The Biotech Industry
Amicus Therapeutics Inc.
NASDAQ: FOLD
FOLD Trading
0.14% G/L:
$14.355 Last:
2,186,418 Volume:
$14.34 Open:
FOLD Latest News
February 20, 2026 04:01:00 pm
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
FOLD Stock Data
$4,416,657,740
301,745,810
0.4%
110
N/A
Biotechnology & Life Sciences
Healthcare
US
Princeton
